Pfizer
Lindsay Havern has extensive experience in compliance governance, risk management, and legal counsel. Lindsay has held various roles at Pfizer, including Vice President, Compliance Governance, Science, Manufacturing, & Corporate Affairs, where they led a team responsible for quality and compliance governance and proactive compliance risk management. Lindsay also served as Vice President & Assistant General Counsel, leading the Global Compliance Risk Assessment processes and overseeing the company's compliance monitoring and analytics team. Prior to their time at Pfizer, Lindsay worked as a Partner at DLA Piper, specializing in internal investigations, product liability litigation, and consumer class action defense.
Lindsay Havern obtained a Bachelor's Degree in Political Science and Government from the University of Southern California in 1998. Subsequently, they pursued a Juris Doctor (J.D.) degree at Pepperdine Law from 1998 to 2001.
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.